Current Updates on the STATIC Trial
As trials progress, updates are often made. Please find below information on the upcoming updates to the STATIC trial:
- We are working on an update to allow people with CLL who have been treated with acalabrutinib as their second or subsequent line of treatment to join the trial. They will then be randomly selected to have either continuous treatment with acalabrutinib or pause their treatment until their CLL comes back, the same as people on the trial on ibrutinib.
As part of this update people with CLL who have been treated with ibrutinib as their first and only of treatment as part of the IcICLLe trial or in standard care within the NHS will also be able to join the trial. They will then be randomly selected to have either continuous treatment with ibrutinib or pause their treatment until their CLL comes back.
Not all hospitals that are on the STATIC trial will make these change at the same time, therefore, please ask your hospital team directly about joining the trial.